BrainStorm Cell Therapeutics
BCLI
#10977
Rank
C$12.68 M
Marketcap
C$1.15
Share price
5.13%
Change (1 day)
19.07%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total assets

Total assets on the balance sheet as of June 2026 : C$1.1 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total assets are C$1.1 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BrainStorm Cell Therapeutics - Total assets on balance sheet (from 2002 to 2026)

Total assets by year

Year Total assets Change
2025-12-31C$1.39 M-46.76%
2024-12-31C$2.62 M-52.9%
2023-12-31C$5.58 M-51.33%
2022-12-31C$11.46 M-69.27%
2021-12-31C$37.31 M-42.91%
2020-12-31C$65.35 M665.88%
2019-12-31C$8.53 M-44.2%
2018-12-31C$15.29 M6.5%
2017-12-31C$14.36 M-0.73%
2016-12-31C$14.46 M-38.94%
2015-12-31C$23.69 M106%
2014-12-31C$11.5 M128.62%
2013-12-31C$5.03 M-1.53%
2012-12-31C$5.1 M83.05%
2011-12-31C$2.79 M156.41%
2010-12-31C$1.08 M36.67%
2009-12-31C$0.79 M-25.13%
2008-12-31C$1.06 M-1.53%
2007-12-31C$1.08 M28.35%
2006-12-31C$0.84 M
2006-03-31C$1.01 M-5.2%
2005-03-31C$1.06 M4929.2%
2004-03-31C$0.02 M-68.24%
2003-03-31C$0.06 M-34.21%
2002-03-31C$0.1 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Biogen
BIIB
C$44.96 B 4,071,803.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$69.17 B 6,264,113.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
C$5.09 B 461,100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C$2.69 B 244,132.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.24 B 21,815.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA